G-CSF製剤バイオシミラーの世界市場:種類別(ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子)、用途別(血液疾患、腫瘍性疾患、慢性・自己免疫疾患、成長ホルモン欠乏症)、地域別予測

【英語タイトル】Global G-CSF Biosimilars Market Size study, by Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies) and Regional Forecasts 2018-2025

Bizwit Research & Consultingが出版した調査資料(BZW9FB033)・商品コード:BZW9FB033
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2019年2月9日
・ページ数:約150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
・産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥442,400見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥621,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本資料は、G-CSF製剤バイオシミラーの世界市場について調べ、G-CSF製剤バイオシミラーの世界規模、市場動向、市場環境、種類別(ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子)分析、用途別(血液疾患、腫瘍性疾患、慢性・自己免疫疾患、成長ホルモン欠乏症)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはPfizer 、Novartis、Roche、Merck & Co.、Sanofi、Johnson & Johnson、Gilead Science、GlaxoSmithKline、AbbVie、Amgen、AstraZeneca 、Bayerなどです。
・イントロダクション
・エグゼクティブサマリー
・G-CSF製剤バイオシミラーの世界市場概要
・G-CSF製剤バイオシミラーの世界市場環境
・G-CSF製剤バイオシミラーの世界市場動向
・G-CSF製剤バイオシミラーの世界市場規模
・G-CSF製剤バイオシミラーの世界市場規模:種類別(ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子)
・G-CSF製剤バイオシミラーの世界市場規模:用途別(血液疾患、腫瘍性疾患、慢性・自己免疫疾患、成長ホルモン欠乏症)
・G-CSF製剤バイオシミラーの世界市場:地域別市場規模・分析
・G-CSF製剤バイオシミラーの北米市場規模・予測
・G-CSF製剤バイオシミラーのアメリカ市場規模・予測
・G-CSF製剤バイオシミラーのヨーロッパ市場規模・予測
・G-CSF製剤バイオシミラーのアジア市場規模・予測
・G-CSF製剤バイオシミラーの日本市場規模・予測
・G-CSF製剤バイオシミラーの中国市場規模・予測
・関連企業情報
【レポートの概要】

Global G-CSF Biosimilars Market to reach USD XX billion by 2025.

Global G-CSF Biosimilars Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The G-CSF Biosimilars Market is continuously growing across the world over the coming years. Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. GCSF stimulates granulocyte production in BM suppressed by chemotherapy and radiotherapy and reduces infections in cancer patients. It can induce terminal maturation of myeloid leukemia cells, resulting in complete hematologic and cytologic remission, and can suppress self-renewal. It is useful in patients with AIDS or leukemic relapse after allogeneic BM transplantation. Increasing aging population, growing incidence of chronic diseases and rising healthcare expenditure are the substantial driving factors of the market across the globe. In addition, growing acceptance due to their cost-effectiveness is also boosting the market growth over the upcoming years. Furthermore, patent expiry of biologic products is the major factor which creating numerous opportunity in the market over the coming years. However, complications associated with manufacturing of G-CSF biosimilars are the factors which limiting the market growth of G-CSF Biosimilars over the coming years. The regional analysis of Global G-CSF Biosimilars Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
The major market player included in this report are:
• Pfizer
• Novartis
• Roche
• Merck & Co.
• Sanofi
• Johnson & Johnson
• Gilead Science
• GlaxoSmithKline
• AbbVie
• Amgen
• AstraZeneca
• Bayer

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

 Human Growth Hormone
 Erythropoietin
 Monoclonal Antibodies
 Insulin
 Interferon
 Granulocyte-Colony Stimulating Factor

By Application:

 Blood Disorders
 Oncology Diseases
 Chronic and Autoimmune Diseases
 Growth Hormone Deficiencies

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global G-CSF Biosimilars Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. G-CSF Biosimilars Market, by Type, 2015-2025 (USD Billion)
1.3.2. G-CSF Biosimilars Market, by Application, 2015-2025 (USD Billion)
1.3.3. G-CSF Biosimilars Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. G-CSF Biosimilars Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. G-CSF Biosimilars Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. G-CSF Biosimilars Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labor Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. G-CSF Biosimilars Market, by Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. G-CSF Biosimilars Market, Sub Segment Analysis
5.4.1. Human Growth Hormone
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Erythropoietin
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.3. Monoclonal Antibodies
5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.4. Insulin
5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.5. Interferon
5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.6. Granulocyte-Colony Stimulating Factor
5.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. G-CSF Biosimilars Market, by Application
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. G-CSF Biosimilars Market, Sub Segment Analysis
6.4.1. Blood Disorders
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. Oncology Diseases
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Chronic and Autoimmune Diseases
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Growth Hormone Deficiencies
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. G-CSF Biosimilars Market, by Regional Analysis
7.1. G-CSF Biosimilars Market, Regional Market Snapshot (2015-2025)
7.2. North America G-CSF Biosimilars Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3. Europe G-CSF Biosimilars Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. France
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Rest of Europe
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4. Asia G-CSF Biosimilars Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5. Latin America G-CSF Biosimilars Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6. Rest of The World
7.6.1. South America
7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2. Middle East and Africa
7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Pfizer
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Novartis
8.3.3. Roche
8.3.4. Merck & Co.
8.3.5. Sanofi
8.3.6. Johnson & Johnson
8.3.7. Gilead Science
8.3.8. GlaxoSmithKline
8.3.9. AbbVie
8.3.10. Amgen
8.3.11. AstraZeneca
8.3.12. Bayer
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF G-CSF BIOSIMILARS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF G-CSF BIOSIMILARS MARKET
TABLE 3. G-CSF BIOSIMILARS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD BILLION)
TABLE 8. G-CSF BIOSIMILARS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. G-CSF BIOSIMILARS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44. G-CSF BIOSIMILARS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. U.S. G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CANADA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. UK G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. GERMANY G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. ROE G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. CHINA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. INDIA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84. JAPAN G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89. ROAPAC G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94. BRAZIL G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99. MEXICO G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104. ROLA G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109. ROW G-CSF BIOSIMILARS MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

FIG 1. G-CSF BIOSIMILARS MARKET, RESEARCH METHODOLOGY
FIG 2. G-CSF BIOSIMILARS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. G-CSF BIOSIMILARS MARKET, KEY TRENDS 2016
FIG 5. G-CSF BIOSIMILARS MARKET, GROWTH PROSPECTS 2017-2025
FIG 6. G-CSF BIOSIMILARS MARKET, PORTERS 5 FORCE MODEL
FIG 7. G-CSF BIOSIMILARS MARKET, PEST ANALYSIS
FIG 8. G-CSF BIOSIMILARS MARKET, VALUE CHAIN ANALYSIS
FIG 9. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 23. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 24. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 25. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 26. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 27. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 28. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 29. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 30. G-CSF BIOSIMILARS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 31. G-CSF BIOSIMILARS MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32. NORTH AMERICA G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 33. EUROPE G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 34. ASIA PACIFIC G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 35. LATIN AMERICA G-CSF BIOSIMILARS MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 36. G-CSF BIOSIMILARS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

【掲載企業】

Pfizer 、Novartis、Roche、Merck & Co.、Sanofi、Johnson & Johnson、Gilead Science、GlaxoSmithKline、AbbVie、Amgen、AstraZeneca 、Bayer

★調査レポート[G-CSF製剤バイオシミラーの世界市場:種類別(ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子)、用途別(血液疾患、腫瘍性疾患、慢性・自己免疫疾患、成長ホルモン欠乏症)、地域別予測] (コード:BZW9FB033)販売に関する免責事項を必ずご確認ください。
★調査レポート[G-CSF製剤バイオシミラーの世界市場:種類別(ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子)、用途別(血液疾患、腫瘍性疾患、慢性・自己免疫疾患、成長ホルモン欠乏症)、地域別予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆